CLEVER HANDELN

Richten Sie Börsennews.de als Startseite ein

Hier klicken

Oxygen Biotherapeutics

Der börsennews.de Newsüberblick zum Thema "Oxygen Biotherapeutics"

DJ EANS-Adhoc: Oxygen Biotherapeutics Reports Second Quarter FY2012 Financial Results.-Management to host teleconference to discuss financial results on December 19-

11:38 Uhr 17.12.2011

... Europe-wide distribution. The issuer is solely responsible for the content of this announcement. =------------------------------------------------------------------------------- 17.12.2011 MORRISVILLE, NC, December 16, 2011 -- Oxygen Biotherapeutics, Inc. (NASDAQ and SIX Swiss Exchange: OXBT), a development stage biomedical company focused on developing oxygen-rich intravenous and topical products,... weiter lesen

DJ EANS-Adhoc: Oxygen Biotherapeutics Announces Registered Financing for up to $7.5 million in Gross Proceeds

18:05 Uhr 09.12.2011

... Europe-wide distribution. The issuer is solely responsible for the content of this announcement. =------------------------------------------------------------------------------- 09.12.2011 MORRISVILLE, NC, December 9, 2011 - Oxygen Biotherapeutics, Inc. (NASDAQ & SIX Swiss Exchange: OXBT) today announced that it has entered into definitive agreements with institutional investors for... weiter lesen

EANS Adhoc: Oxygen Biotherapeutics Inc. (deutsch)

06:31 Uhr 28.10.2011

EANS-Adhoc: Oxygen Biotherapeutics macht Sekundärkotierung an SIX rückgängig -------------------------------------------------------------------------------- Ad-hoc-Mitteilung übermittelt durch euro adhoc mit dem Ziel einer europaweiten Verbreitung. Für den Inhalt... weiter lesen

DJ EANS-Adhoc: Oxygen Biotherapeutics macht Sekundärkotierung an SIX rückgängig

04:30 Uhr 28.10.2011

... adhoc mit dem Ziel einer europaweiten Verbreitung. Für den Inhalt ist der Emittent verantwortlich. =------------------------------------------------------------------------------- 28.10.2011 MORRISVILLE, North Carolina, USA -- Oxygen Biotherapeutics, Inc. (NASDAQ & SIX Swiss Exchange: OXBT) gibt heute bekannt, dass die SIX Swiss Stock Exchange dem Antrag des Unternehmens... weiter lesen

DJ EANS-Adhoc: Oxygen Biotherapeutics to Voluntarily Withdraw Secondary Listing from SIX Swiss Stock Exchange

04:30 Uhr 28.10.2011

... Europe-wide distribution. The issuer is solely responsible for the content of this announcement. =------------------------------------------------------------------------------- 28.10.2011 MORRISVILLE, NC, October 27, 2011 - Oxygen Biotherapeutics, Inc. (NASDAQ & SIX: OXBT) today announced that the SIX Swiss Stock Exchange has approved the application filed by the... weiter lesen

DJ EANS-Adhoc: Oxygen Biotherapeutics Reports First Quarter FY2012 Financial Results and Announces Conference Call and Webcast for Shareholders

04:30 Uhr 20.09.2011

... Europe-wide distribution. The issuer is solely responsible for the content of this announcement. =------------------------------------------------------------------------------- 20.09.2011 MORRISVILLE, NC, September 19, 2011 -- Oxygen Biotherapeutics, Inc. (NASDAQ and SIX Swiss Exchange: OXBT), a development stage biomedical company focused on developing oxygen-rich intravenous and topical products,... weiter lesen

DJ EANS-Adhoc: Oxygen Biotherapeutics Announces Dismissal of Chris J. Stern as CEO and Appointments of Michael B. Jebsen as Interim CEO and Rene Eckert as Interim Chairman. -Oxygen Biotherapeutics to reschedule its 2011 General Annual Meeting of Stockhold

05:18 Uhr 25.08.2011

... is solely responsible for the content of this announcement. =------------------------------------------------------------------------------- 25.08.2011 MORRISVILLE, NC, August 24, 2011-- The Board of Directors of Oxygen Biotherapeutics, Inc. (NASDAQ & SIX Swiss Exchange: OXBT) today announced that Chris J. Stern is no longer Chief Executive Officer and... weiter lesen

DJ EANS-Adhoc: Oxygen Biotherapeutics und Aurum Biosciences unterzeichnen Absichtserklärung zur Erforschung von Oxycyte® PFC für Imaging und therapeutische Interventionen bei akutem ischämischem Hirnschlag.

04:30 Uhr 25.07.2011

... adhoc mit dem Ziel einer europaweiten Verbreitung. Für den Inhalt ist der Emittent verantwortlich. =------------------------------------------------------------------------------- 25.07.2011 MORRISVILLE, North Carolina, USA -- Oxygen Biotherapeutics, Inc. (NASDAQ & SIX Swiss Exchange: OXBT) und das Privatunternehmen Aurum Biosciences Ltd. aus Glasgow, Schottland, geben bekannt, dass sie... weiter lesen

DJ EANS-Adhoc: Oxygen Biotherapeutics and Aurum Biosciences Sign Letter of Intent to Explore the Use of Oxycyte® PFC for Imaging and Therapeutic Intervention of Acute Ischemic Stroke

04:30 Uhr 25.07.2011

... Europe-wide distribution. The issuer is solely responsible for the content of this announcement. =------------------------------------------------------------------------------- 25.07.2011 MORRISVILLE, NC, July 25, 2011 - Oxygen Biotherapeutics, Inc. (NASDAQ & SIX Swiss Exchange: OXBT) and privately held Aurum Biosciences Ltd. of Glasgow, Scotland, today announced they signed... weiter lesen

DJ EANS-Adhoc: Oxygen Biotherapeutics Reports Financial Results for Fiscal Year 2011

04:30 Uhr 15.07.2011

... Europe-wide distribution. The issuer is solely responsible for the content of this announcement. =------------------------------------------------------------------------------- 15.07.2011 MORRISVILLE, NC, July 14, 2011 -- Oxygen Biotherapeutics, Inc. (NASDAQ and SIX Swiss Exchange: OXBT), a development stage biomedical company focused on developing oxygen-rich intravenous and topical products,... weiter lesen

Mehr zu Oxygen Biotherapeutics
  1. 1
  2. 2
  3. 3
  4. ›
  5. »